QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guyman, L. A. Articles by Lampe, J. W. Search for Related Content PubMed PubMed Citation Articles by Guyman, L. A. Articles by Lampe, J. W. Pubmed/NCBI databases Medline Plus Health Information Diets

---

Nutritional Epidemiology

Urinary 3-(3,5-Dihydroxyphenyl)-1-Propanoic Acid, an Alkylresorcinol Metabolite, Is a Potential Biomarker of Whole-Grain Intake in a U.S. Population^1,2

³ Interdisciplinary Graduate Program in Nutritional Sciences, University of Washington, Seattle, WA 98195-3410; ⁴ Fred Hutchinson Cancer Research Center, Seattle, WA 98109; ⁵ Institute for Preventive Medicine, Nutrition and Cancer, Folkhälsan Research Center and Division of Clinical Chemistry, University of Helsinki, Helsinki, Finland; and ⁶ Department of Epidemiology, University of Washington, Seattle, WA 98195-7236

^* To whom correspondence should be addressed. E-mail: jlampe{at}fhcrc.org.

5-n-Alkylresorcinols (AR) are a major group of phenolic compounds in whole-grain wheat, rye, and barley. As such, they may serve as potential biomarkers of whole-grain intake, because they are quantifiable intact in plasma and as metabolites in urine. We examined relationships between 12-h urinary excretion of AR metabolite 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA) and self-reported habitual intake of whole-grain foods measured by 3-d food record (3DFR) and FFQ. Urine samples from 100 men and women were analyzed for DHPPA using HPLC with coularray detection. DHPPA excretion ranged from 1.3 to 99.4 (mean ± SE, 14.0 ± 1.5) µmol/12 h. Whole-grain food intake, as determined by 3DFR and FFQ and adjusted for BMI and energy and fiber intake, was significantly associated with 12-h urinary DHPPA excretion. Based on 3DFR, whole-grain wheat + rye consumers had a 44% higher DHPPA excretion than nonconsumers [ratio of excretion (95% CI) = 1.44 (1.04, 1.97); P = 0.029]. Using whole-grain intake estimated by FFQ, a serving increase in whole-grain wheat + rye intake increased DHPPA excretion by 94% [ratio of excretion (95% CI) = 1.94 (1.35, 2.78); P = 0.001] and a serving increase in whole grains as defined more broadly in epidemiologic studies of whole-grain intake and disease risk (whole-grain wheat, rye, oats, and corn) increased DHPPA by 67% [ratio of excretion (95% CI) = 1.67 (1.28, 2.17); P < 0.0001]. This study supports the potential utility of urinary DHPPA as a biomarker of whole-grain intake in a U.S. population.

This article has been cited by other articles:

				P. P Soderholm, A. H Koskela, J. E Lundin, M. J Tikkanen, and H. C Adlercreutz Plasma pharmacokinetics of alkylresorcinol metabolites: new candidate biomarkers for whole-grain rye and wheat intake Am. J. Clinical Nutrition, November 1, 2009; 90(5): 1167 - 1171. [Abstract] [Full Text] [PDF]